Clinical trial
Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population
NCT07330830 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Guadeloupe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population
- Lead sponsor
- Centre Hospitalier Universitaire de la Guadeloupe
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 26, 2025
- Completion date
- November 28, 2027
- Enrollment
- 600 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
masld/mash (metabolic dysfunction-associated steatotic liver disease / metabolic dysfunction-associated steatohepatitis)